IL17A and breast carcinoma: TRAF3 interacting protein 2 (TRAF3IP2) is an adaptor protein regulating NF-κB signaling downstream of the IL-17 pathway and is known to promote proinflammatory and proangiogenic signaling in glioblastoma and breast cancer [47,48].